Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002460200 on April 25, 2000

J. Biol. Chem., Vol. 275, Issue 27, 20588-20596, July 7, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/27/20588    most recent
M002460200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, S. K.
Right arrow Articles by Hirsh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, S. K.
Right arrow Articles by Hirsh, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Type II cAMP-dependent Protein Kinase-deficient Drosophila Are Viable but Show Developmental, Circadian, and Drug Response Phenotypes*

Sang Ki Park, Stacey A. Sedore, Claire Cronmiller, and Jay HirshDagger

From the Department of Biology, University of Virginia, Charlottesville, Virginia 22903

Received for publication, March 23, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We identified a unique type II cAMP-dependent protein kinase regulatory subunit (PKA-RII) gene in Drosophila melanogaster and a severely hypomorphic if not null mutation, pka-RIIEP(2)2162. Extracts from pka- RIIEP(2)2162 flies selectively lack RII-specific autophosphorylation activity and show significantly reduced cAMP binding activity, attributable to the loss of functional PKA-RII. pka-RIIEP(2)2162 shows 2-fold increased basal PKA activity and ~40% of normal cAMP-inducible PKA activity. pka-RIIEP(2)2162 is fully viable but displays abnormalities of ovarian development and multiple behavioral phenotypes including arrhythmic circadian locomotor activity, decreased sensitivity to ethanol and cocaine, and a lack of sensitization to repeated cocaine exposures. These findings implicate type II PKA activity in these processes in Drosophila and imply a common role for PKA signaling in regulating responsiveness to cocaine and alcohol.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

cAMP is a widely used second messenger that participates in a plethora of cellular, neural, and developmental processes. Neural functions of cAMP signaling include roles in a number of plastic responses, including learning and memory (1-6), synaptic transmission (7, 8), circadian rhythmicity (9), modulation of photoreceptor responses to light (10), and modulation of responses to alcohol (11, 12) and other drugs of abuse (13, 14). A key intermediate in cAMP signaling is cAMP-dependent protein kinase, PKA1 (15). PKA acts as a key sensor of cellular cAMP levels and mediates the flow of signals to downstream effector pathways by phosphorylating their targets. PKA is a heterotetrameric holoenzyme composed of two catalytic subunits (C2) and a homodimer of regulatory subunits (R2). The R2 homodimer not only inhibits the catalytic activity of the C subunits but also stabilizes C subunits against proteolytic degradation in the PKA heterotetramer. Binding of cAMP to the R subunits of the holoenzyme results in dissociation of R and C subunits, which are then catalytically active. These general features of PKA signaling are shared by most eukaryotic organisms.

PKA can be formed from several types of C and R subunits that can endow the PKA heterodimer with different signaling and subcellular localization properties. The three subtypes of C subunits (Calpha , Cbeta , and Cgamma ) have virtually identical kinetic and physiological properties (15). By contrast, the different R subunit types, RI and RII, exhibit distinct cAMP binding affinities and are differentially localized in cells, leading to PKA holoenzymes termed PKAI or PKAII, respectively. PKAI holoenzyme is predominantly cytoplasmic, whereas the majority of PKAII associates with cellular structures and organelles (16). This subcellular localization is largely mediated by anchoring of RII subunits to protein kinase A-anchoring proteins (AKAPs). RII subunits bind to AKAPs with nanomolar affinity (17), whereas RI subunits only bind weakly to AKAPs (18). Adding to this complexity, higher vertebrates express two types of RI and RII genes that have different spatial patterns of expression (19).

In Drosophila, genetic and molecular approaches have led to the identification of a type I R subunit (pka-RI) and three genes for catalytic subunit isoforms, pka-C1 (also known as DC0), pka-C2, and pka-C3 (20). Both RI and RII PKA subunits have also been detected biochemically. PKA-RI is detectable during larval stages and early and mid-pupation (21), although its transcripts can be detected in the adult mushroom bodies of the brain (5). Consistent with this expression pattern, a pka-RI mutant shows learning defects (5). PKA-RII is expressed much more abundantly than PKA-RI in adult Drosophila (21), and its expression is largely restricted to the nervous system, where it is also preferentially expressed in mushroom bodies (22). The Drosophila gene encoding PKA-RII has not been previously identified.

From the analysis of pka-C1 and other cAMP signaling genes such as amnesiac (amn, a PACAP-like adenylate cyclase-activating peptide), pka-RI (5), rutabaga (rut, Ca2+/CaM-responsive adenylate cyclase), and dunce (dnc, cAMP phosphodiesterase), there is functional evidence for the involvement of cAMP signaling in learning and memory (3), ovarian development (23), maintenance of circadian locomotor rhythmicity (9), and modulation of the sensitivity to ethanol intoxication (11) in Drosophila. In addition, PKA signaling functions in the widely used hedgehog signaling pathway (reviewed in Ref. 24).

Despite the aforementioned analyses, separable roles for PKAI versus PKAII signaling have been difficult to discern. In mouse, knockout of the RIIbeta gene leads to experience-dependent locomotor defects and hypersensitization to repeated amphetamine exposures (14). These phenotypes could be due to the loss of the RIIbeta subunit, but there are compensatory increases in other RI and RII subunits that could also explain the effects. Similar compensation is seen in RIalpha -deficient mice (25). In flies, the pka-RI mutant shows a learning deficit, but this may not be the full extent of pka-RI functions, since this mutant retains significant PKA-RI expression (5).

Here we identify the Drosophila pka-RII gene and mutations that virtually abolish its expression yet are homozygous-viable. We used these PKAII-deficient mutants to analyze the involvement of PKAII in various biological processes in Drosophila.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Fly Strains-- The EP(2)2162 (26) line was obtained from the Berkeley Drosophila Genome Project (BDGP). For genetic background controls, randomly selected EP lines (EP(2)0844, EP(X)1529, and EP(X)1192) were used, as well as w1118.

Autophosphorylation Analysis-- Autophosphorylation analysis was carried out as described in Foster et al. (21) with modifications. Briefly, protein extracts were prepared from whole flies by homogenizing the frozen flies in Buffer A (5 mM EDTA, 50 mM Tris, pH 7.5) and subsequently centrifuging at 10,000 × g for 30 min. The protein concentration of supernatants was determined by the Bradford method. A volume of extract containing 30 µg of protein was incubated with 0.5 µCi of [gamma -32P]ATP (NEN Life Science Products) without additional cold ATP in the presence or absence of 10 µM cAMP in a total volume of 20 µl of Buffer B (10 mM beta -mercaptoethanol, 10 mM MgCl2, 1 mM EDTA, 50 mM Tris, pH 7.5) for 10 min on ice. The reaction was stopped by addition of 20 µl of 2× SDS gel loading buffer. 20 µl of assay mixture was separated on a 10% SDS-polyacrylamide gel. The gel was fixed, dried, and autoradiographed.

Western Blotting-- A volume of whole fly extract containing 15 µg of protein from each genotype was separated in an SDS-10% polyacrylamide gel and transferred to the nitrocellulose membrane. The blot was blocked with 3% dried nonfat milk in TBS (25 mM Tris, 137 mM NaCl, 2 mM KCl, pH 8.0) for 30 min and incubated with anti-RII antiserum (generously provided by Dr. D. Kalderon) for 2 h. After washing three times with TBS, the membrane was incubated with horseradish peroxidase-conjugated anti-rabbit goat IgG (Roche Molecular Biochemicals) for 2 h at room temperature and then washed with TBS three times. Immunoreactivity was visualized using the ECL system (Amersham Pharmacia Biotech) following the manufacturer's instructions. Kodak Image Station CF440 (Eastman Kodak Co.) was used to develop the image and to analyze the relative density of signals.

cAMP Binding Assay-- cAMP binding activity was measured by the method described in Kumon et al. (27). A volume of extract containing 30 µg of protein was incubated with 1 µCi of 3',5'-(2',8'-3H]cAMP (ICN, Costa Mesa, CA) in a total volume of 100 µl of Buffer C (50 mM sodium acetate, pH 4.5, 10 mM MgCl2) for 2 h on ice. Reaction mixtures were subsequently filtered through nitrocellulose filters (Millipore, Bedford, MA), and the filters were washed 10 times with Buffer C. The radioactivities of dried nitrocellulose filters were measured.

PKA Activity Assay-- A volume of extract containing 30 µg of protein was incubated with 50 µM Kemptide, Leu-Arg-Arg-Ala-Ser-Leu-Gly (Life Technologies, Inc.), in a total volume of 40 µl of Buffer D (10 mM MgCl2, 0.1 mM ATP supplemented with 2 µCi of [gamma -32P]ATP, 0.25 mg/ml bovine serum albumin, 50 mM Tris, pH 7.5) in the presence and/or absence of 10 µM cAMP and 1 µM of PKA inhibitor-(6-22)-amide (Life Technologies, Inc.) for 5 min at 30 °C. Incorporation of phosphates to Kemptide was measured by spotting the 20 µl of assay mixture onto Whatman P-81 paper and subsequent washing with 1% phosphoric acid. Calculations of kinase activity were based on the fraction inhibited by PKA inhibitor-(6-22)-amide of total incorporation.

Ovary Staining-- To visualize nuclei, 4',6-diamidino-2-phenylindole staining was performed according to the procedure of Ruohola et al. (48). To highlight cell outlines and ring canals, rhodamine-conjugated phalloidin was added at the same time as 4',6-diamidino-2-phenylindole.

Locomotor Activity Assay-- Male flies kept at 18 °C were exposed to four cycles of 12-h light-12-h dark (LD, where zeitgeber time 0 (ZT0) is lights on and 12 (ZT12) is light off), followed by 10-12 days in constant dark (DD) conditions in a locomotor activity monitor (Trikinetics, Waltham, MA). Wild type and mutant flies were tested simultaneously in a given experiment. The free running periods of individual flies during DD were estimated by chi 2 periodogram analyses. Only data from flies that survived to the end of the activity monitoring were used for further analyses.

Ethanol Sensitivity Assay-- Humidified ethanol vapor from a 50% ethanol:H2O (v/v) solution was pumped in parallel into the top of two 50-ml tubes (Falcon, Lincoln Park, NJ). The tubes have a number of small holes near the bottom to allow escape of vapors. 30 unanesthetized male flies were transferred to each tube, and the number of flies immobilized on the bottom was counted every 5 min. In test runs, the identical genotypes run in parallel showed no significant difference in KO50, the time elapsed until 50% of flies are immobilized to the bottom of a tube. Ethanol in the whole body extracts was determined as described in Moore et al. (11). A volume of extract containing 30 µg of protein was added to the 500 µl of alcohol reagent (Sigma) and incubated for 5 min at 37 °C, and absorbance at 340 nm was measured. This was converted to ethanol concentration by assaying ethanol standards provided by the manufacturer.

Cocaine Behavioral Assays-- Free-base cocaine was administered as described previously (28). To evoke the substantial initial response required for sensitization to the subsequent exposure in pka- RIIEP(2)2162, higher doses of cocaine were used. The second exposure was given 6 h after the first exposure.

Reversion Analysis-- To generate revertants, homozygous pka- RIIEP(2)2162 flies were crossed with a transposase line (y, w; Bc/CyO, Delta 2-3) and the male progeny with variegated eyes were collected and crossed with y, w; Gla/CyO. White eye progeny were collected and crossed individually with y, w; Gla/CyO and maintained as stocks. Reversion was verified by polymerase chain reaction using the primers (forward, 5'-GATGCGATCACCATAACGGCCCTTA-3',and reverse, 5'-GCGCGAAGCTGGAGTTAATTTGCG A-3') for the region that the P element had been inserted. Subsequent nucleotide sequencing of polymerase chain reaction products was carried out at the University of Virginia Health Science Center Biomolecular Research Facility.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Molecular Characterization of a PKA-RII in Drosophila-- We identified a cDNA encoding a Drosophila homolog of a type II regulatory subunit of cAMP-dependent protein kinase (PKA-RII) in the BDGP EST data base through BLAST searches based on the primary protein sequences of known PKA-RII proteins. These searches identified a single cDNA clone, LD44591, in BDGP cDNA collections, which was subsequently sequenced in its entirety. The cDNA encodes a deduced 42.7-kDa protein that retains significant similarities to vertebrate PKA-RII proteins and the previously identified Drosophila PKA-RI (Fig. 1). The most striking similarities are observed in four cyclic nucleotide-binding domain signatures (residues 151-167, 187-204, 269-285, and 309-326) that form two cAMP/cGMP-binding motifs (residues 124-239 and 242-362, indicated by bars in Fig. 1). Also observed is a PKA autophosphorylation site (residues 81-84, indicated by an asterisk in Fig. 1), a unique feature of type II PKA regulatory subunits (29). It also contains amino acid sequences that have been identified by peptide sequencing from biochemically purified Drosophila PKA-RII (30), indicated by dashes in Fig. 1).


View larger version (147K):
[in this window]
[in a new window]
 
Fig. 1.   Deduced amino acid sequence of Drosophila PKA-RII aligned with known PKA-RII proteins. Multiple protein sequence alignment for PKA-RII proteins and a Drosophila PKA-RI was carried out using ClustalW. The order of the sequences is based on the degree of similarity. Identical amino acid residues are indicated by dark boxes, and the residues that show similarity are indicated by shaded boxes. Primary structure of PKA-RII was analyzed by scanning the sequence against the pattern or profile entries in PROSITE and Swiss-Prot. Bars indicate cyclic nucleotide-binding motifs, and dashes indicate the peptide sequences of purified Drosophila PKA-RII reported by Inoue and Yoshiokda (30). The asterisk indicates the phosphorylation site for PKA.

Characterization of pka-RII Gene and Identification of a pka-RII Mutant-- Genomic DNA sequences corresponding to Drosophila PKA-RII cDNA were retrieved from the BDGP genomic sequence data base, and polymerase chain reaction amplification and subsequent DNA sequencing were carried out to determine the full genomic DNA sequence. Ten exons are dispersed throughout the >15-kilobase pair genomic region that is localized in the proximal part of chromosome 2R in polytene region 46D1-46D2 (Fig. 2A). The data base searches also led to the identification of a P insertion mutant, EP(2)2162, inserted 89 base pairs upstream of the predicted transcription start site corresponding to the sequence of LD44591 clone in a position that could block transcription of pka-RII. This insertion line is homozygous-viable and fertile with no obvious behavioral or developmental phenotypes.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 2.   EP(2)2162 line is a PKA-RII mutant. A, schematic diagram of the pka-RII gene. Open boxes indicate exons for 5'- and 3'-untranslated regions, and closed boxes represent exons for coding region. pka-RIIEP(2)2162 has an EP element (26) inserted 89 base pairs upstream of the predicted transcription start site. B, lack of PKA-RII autophosphorylation in the pka-RIIEP(2)2162 extract. Whole fly extracts from wild type (lanes 1 and 2) and pka-RIIEP(2)2162 (lanes 3 and 4) flies were incubated with [gamma -32P]ATP in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of cAMP (see "Experimental Procedures"). PKA-RII (apparent mass of ~57 kDa, closed arrow) is phosphorylated in a cAMP-sensitive manner. An ~70-kDa band whose phosphorylation was not affected by cAMP is indicated by open arrow. Molecular weight standards are indicated at the left. C, reduced PKA-RII protein in the pka-RIIEP(2)2162 extract. Whole fly extracts from wild type (WT, lane 1) and pka-RIIEP(2)2162 (lanes 2) flies were analyzed by SDS-10% polyacrylamide gel electrophoresis and subsequent Western blotting (see "Experimental Procedures"). The intensity of the ~52-57-kDa PKA-RII bands (indicated by a closed arrow) was reduced ~10-fold in the pka-RIIEP(2)2162 extract. Molecular weight standards are indicated at the left. D, decreased cAMP binding activity in the pka-RIIEP(2)2162 extract. The cAMP binding activity of three whole body extracts from pka-RIIEP(2)2162 and wild type flies were assayed in duplicate. The data points represent the mean ± S.E. ** indicates statistical significance of the difference between genotypes determined by one-tailed t test; p < 0.001.

To see the effect of this insertion on the expression of PKA-RII protein, we tested the cAMP-sensitive autophosphorylation of PKA-RII in whole fly extracts from wild type and EP(2)2162 lines (see "Experimental Procedures"). ATP concentration in the reactions was maintained low enough to allow predominant intramolecular RII autophosphorylation that is blocked by cAMP addition and subsequent C subunit dissociation (31). The autophosphorylation reaction leads to the phosphorylation of ~57- and ~70-kDa proteins (Fig. 2B). The 57-kDa protein, which is phosphorylated in a cAMP-sensitive manner, is reduced by >95% in the EP(2)2162 extracts (Fig. 2B), and the phosphorylation of the 70-kDa protein is increased about 2-fold. Given that cAMP-sensitive phosphorylation occurs only on the PKA-RII that is electrophoretically determined to be about ~52 kDa in its dephosphoform and ~57 kDa in its phosphoform in Drosophila (21), this result indicates that EP(2)2162 does not express a functional PKA-RII. Consistent with this, by Western blotting analysis (Fig. 2C), RII immunoreactivity is reduced ~10-fold in EP(2)2162 extract. In addition, the EP(2)2162 extract contains significantly reduced cAMP binding activity (Fig. 2D) attributable to the absence of PKA-RII, a major cellular cAMP-binding protein (32). Taken together, the EP element in EP(2)2162 disrupts the normal expression of PKA-RII causing a severe, if not null, mutation of pka-RII, which we subsequently refer to as pka-RIIEP(2)2162. Since BLAST searches against the Drosophila euchromatic genomic sequence data base fail to show any additional pka-RII candidate genes (data not shown), pka-RIIEP(2)2162 likely represents the first animal in which PKAII activity is effectively eliminated.

We note that the PKA-RII cDNA encodes a deduced 42.7-kDa protein, significantly smaller than the apparent size by electrophoretic mobility. A similar size discrepancy is observed in bovine PKA-RII, with deduced molecular mass of 45 kDa and apparent molecular mass of 58 kDa (33). This suggests that the structural properties of PKA-RII proteins that induce the size discrepancy are conserved among these diverse organisms.

pka-RIIEP(2)2162 Shows Altered PKA Activity-- In mouse, loss of PKA regulatory subunits by genetic manipulations leads to reduction of cAMP-inducible PKA activity mainly due to proteolytic degradation of free PKA C subunits (25) and compensatory up-regulation of the other PKA regulatory subunits (14). To assess the effect of selective loss of PKA-RII on PKA activity in pka-RIIEP(2)2162, we assayed PKA activity in the total protein extracts from wild type and pka-RIIEP(2)2162 whole flies (Fig. 3). In the absence of exogenous cAMP, the low basal level of PKA activity is significantly increased in the pka-RIIEP(2)2162 extract (Fig. 3a), consistent with an increase in free C subunits due to loss of RII subunits. However, in the presence 10 µM cAMP, the pka-RIIEP(2)2162 extract shows only ~40% of the activity seen in wild type extract (Fig. 3b). The inducibility of PKA activity by excess cAMP is ~70-fold in extracts from wild type flies and ~12-fold in extracts from pka-RIIEP(2)2162 with the reduction of cAMP action attributable to the loss of this major cAMP signaling component.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Altered PKA activity of pka-RIIEP(2)2162. PKA activities of the whole fly extracts from pka-RIIEP(2)2162 and wild type (WT) flies were measured in the absence (a) and presence (b) of 10 µM cAMP. Three homogenates of each genotype were assayed in duplicate. The data points represent the mean ± S.E. The differences in PKA activities are statistically significant between genotypes as determined by one-tailed t test. *, p < 0.05, and **, p < 0.001.

pka-RIIEP(2)2162 Affects Ovarian Development-- Since defects in oogenesis have previously been reported for hypomorphic pka-C1, a PKA catalytic subunit mutant (23, 34), we investigated whether pka-RIIEP(2)2162 ovaries show similar phenotypes (Fig. 4). Approximately 43% (n = 150) of ovarioles from pka-RIIEP(2)2162 flies show defects in follicle formation and maturation. These defects include multinucleate nurse cells, too many or too few nurse cells within a follicle, absence of interfollicular stalks, and an abnormally large number of somatic epithelial cells at the posterior end of the follicle. These phenotypes are very similar, but not identical, to those seen in pka-C1 mutants. In pka-C1 ovaries, multinucleate nurse cells often still contain the ring canal that would have connected the two nurse cells (34), but in pka-RIIEP(2)2162 ovaries, multinucleate cells (brackets, Fig. 4, b and d) have no internal ring canals. Follicles with multinucleate cells also seem to have fewer nurse cells than normal. pka-RIIEP(2)2162 homozygotes also have large follicles where double and triple the normal number of nurse cells is observed, and often, these follicles are not separated from the next follicle by an interfollicular stalk. The similarities between pka-C1 and pka-RIIEP(2)2162 phenotypes indicate that PKAII is a major contributor to PKA signaling during ovarian development.


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 4.   Abnormal ovarian development of pka-RIIEP(2)2162. Ovarioles from wild type (WT, a and c) and pka-RIIEP(2)2162 (b and d) females were stained with 4',6-diamidino-2-phenylindole (DAPI, a and b) to visualize nuclei and rhodamine-conjugated phalloidin (c and d) to show cell outlines. The brackets in b and d indicate an example of a multinucleate nurse cell.

pka-RIIEP(2)2162 Shows Arrhythmic Locomotor Activity-- PKA is also involved in the maintenance of locomotor circadian rhythmicity in Drosophila, functioning downstream of the brain-based circadian pacemaker in an output pathway (9). We analyzed locomotor rhythmicity of pka-RIIEP(2)2162. About 42% of pka-RIIEP(2)2162 flies retain normal circadian rhythmicity in constant environmental conditions (Fig. 5C), consistent with the locomotor analyses of pka-C1 (9), a PKA catalytic subunit mutant. pka-RIIEP(2)2162 entrains normally to LD conditions but the rhythmicity rapidly dampens through following DD conditions (Fig. 5B). In 42% of flies showing rhythmicity, a normal period of ~23.7 h is observed. About 85% of wild type and randomly selected EP lines consistently show normal rhythmicity (Fig. 5, A and C, data not shown).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 5.   Arrhythmic locomotor activity of pka-RIIEP(2)2162. Locomotor activity of individual flies kept at 18 °C was recorded for 4 days in light/dark (LD) cycles followed by 10 days in constant darkness (DD). Average locomotor activities of wild type (WT, A) and pka-RIIEP(2)2162 (B) flies (n = 32 each) in the last day of LD and the 5 subsequent days of DD are shown. Open and solid bars indicate light and dark conditions, respectively. The fractions of flies showing normal rhythmicity from the pool of three independent experiments for each genotype are shown in C. Statistical significance was determined by a chi 2 test; **, p < 0.001, n = 88 for wild type flies, and n = 105 for pka-RIIEP(2)2162.

pka-RIIEP(2)2162 Shows Altered Ethanol Intoxication-- Functional evidence for the involvement of cAMP signal transduction pathway in the ethanol intoxication in Drosophila has been reported (11). Mutations in the gene amn, which is thought to encode a positive regulator of cAMP signaling, increase sensitivity to ethanol intoxication, as assayed by increased rate of passing through an inebriometer. We devised a simple apparatus that allows comparison of ethanol intoxication sensitivity of two groups of flies in parallel, by measuring time for flies to fall to the bottom of a tube through which humidified ethanol vapor is pumped (see "Experimental Procedures"). Multiple alleles of amn were tested using this apparatus. Consistent with the previous report using the inebriometer (11), these amn alleles show shorter KO50 time than wild type or random EP lines (data not shown). In contrast, pka-RIIEP(2)2162 shows robust resistance to ethanol (Fig. 6A) with ~6 min longer KO50 time than wild type flies (Fig. 6B). To verify that the observed phenotype is not due to the altered ethanol permeability or metabolism rate, the amount of ethanol in the whole body extracts of pka-RIIEP(2)2162 and wild type lines was measured (see "Experimental Procedures"). There are no significant differences in permeability and metabolism rates between pka-RIIEP(2)2162 and wild type lines (data not shown).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6.   Decreased ethanol sensitivity of pka-RIIEP(2)2162. 50% ethanol:H2O was pumped into two tubes in parallel, each contains 30 flies of each genotype in parallel, and the number of flies immobilized at the bottom of the tubes were counted (see "Experimental Procedures"). The data points represent the mean ± S.E. from three independent experiments. A, fraction of flies immobilized to the bottom of tubes as a function of exposure time. Open circles, wild type flies; closed circles, pka-RIIEP(2)2162. B, time (min) to immobilize 50% of flies (KO50) as a function of genotypes. Asterisk indicates statistical significance determined by one-tailed t test; p < 0.05, n = 3. WT, wild type.

pka-RIIEP(2)2162 Shows Altered Responsiveness to Cocaine-- In vertebrates, PKA signaling is a key pathway modulating responses to chronic administration of cocaine. We tested the responsiveness of pka-RIIEP(2)2162 to cocaine, a potent motor stimulant in flies (28). The response of pka- RIIEP(2)2162 to the first dose of cocaine is much lower than that of wild type flies and other randomly selected EP lines (Fig. 7). Significantly higher doses of cocaine (180-200 µg) are required to elicit substantial initial responses, which are induced at 75-90 µg of cocaine in wild type lines. Furthermore, subsequent doses of cocaine failed to elicit robust sensitization in pka-RIIEP(2)2162 flies, whereas wild type flies show prominent sensitization (Fig. 7), measured as an enhanced response to the second cocaine exposure.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 7.   Altered cocaine responsiveness of pka-RIIEP(2)2162 to cocaine. Wild type (WT) and pka-RIIEP(2)2162 male flies were given two exposures to volatilized free-base cocaine at a 6-h interval, and the behavioral responses were scored during the 5 min after exposure with a behavioral scale described in McClung and Hirsh (28). The fraction of flies showing behavioral scores of 5 (rapid twirling, erratic jumping, or paralysis) or above is plotted for each exposure. Error bars are standard deviations calculated for binomial distributions. Significant differences in responses to the first versus subsequent exposures were determined by the chi 2 test; *, p < 0.05, or **, p < 0.01.

Reversion of pka-RIIEP(2)2162-- To ascertain that the phenotypes reported are due to the EP(2)2162 element, multiple complete and partial revertants were recovered by mobilizing the P element in pka-RIIEP(2)2162 (see "Experimental Procedures"). Phenotypes were analyzed against their background strain (y,w) and parental strain (pka-RIIEP(2)2162). Complete revertants, pka-RIIrev7 and pka-RIIrev23, show none of the behavioral and developmental defects that are observed in pka-RIIEP(2)2162 (data not shown). Similarly, imprecise excision of the P element resulting in deletion extending to the pka-RII gene yields biochemical and behavioral phenotypes indistinguishable from pka-RIIEP(2)2162, indicating that pka- RIIEP(2)2162 is a severely hypomorphic, if not a null, mutant.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

pka-RIIEP(2)2162 Is Deficient in PKAII-- Type II PKA is the predominant isoform in adult Drosophila (21, 22), yet the pka-RII gene has not been isolated previously. We detect a unique pka-RII gene and a PKA-RII protein species that is autophosphorylated in vitro in a cAMP-sensitive manner. We have not detected other PKA-RII candidate genes in BDGP nucleotide sequence data base that represents most of Drosophila euchromatic DNA sequence. A P element-induced mutation, pka-RIIEP(2)2162, lacks at least 95% of the cAMP-sensitive autophosphorylation activity, characteristic of RII. Furthermore, deletions that extend into pka-RII as a result of imprecise excision of this P element show phenotypes that are no more severe than the initial mutant. Surprisingly, all of these mutants show full viability. These mutants are the first animals in which PKAII activity is essentially abolished, giving substrates for examining the in vivo roles of PKAII signaling.

PKA activity in pka-RIIEP(2)2162 extracts shows reduced cAMP-mediated inducibility, as would be expected for loss of this major cAMP regulatory subunit. This reduction in cAMP inducibility is due to two effects. First, these extracts show increased basal PKA activity measured in the absence of exogenous cAMP relative to wild type, presumably due to an increase in free C subunits that are not coupled with R subunits. Second, pka-RIIEP(2)2162 extracts show reduced PKA activity relative to wild type in the presence of saturating cAMP. In vertebrates, loss of R subunits leads to destabilization of C subunits, making them more susceptible to proteolytic degradation (14, 25). PKA activity at saturating cAMP measures the total C subunit content, which is therefore reduced in pka-RIIEP(2)2162.

Altered Cocaine Responsiveness of pka-RIIEP(2)2162-- PKAII-deficient pka-RIIEP(2)2162 flies show two defects in cocaine responsiveness. First, they are very resistant to cocaine, requiring much higher doses than normal to stimulate locomotor responses. Second, they are defective in sensitization, even when exposed to high enough cocaine doses to yield behavioral responses sufficient to evoke sensitization in wild type flies.

In vertebrates, stimulation of D1-like dopamine receptors subsequent to cocaine exposure results in activation of G-protein-dependent adenylate cyclase and PKA (reviewed in Refs. 35 and 36), and pharmacological activation of adenylate cyclase by cholera toxin produces an augmented behavioral response to an acute injection of cocaine (37). Consistent with these effects, there is an increase in the basal activity of adenylate cyclase and PKA in the nucleus accumbens of the forebrain after repeated cocaine administration (38). The PKA-mediated second messenger system regulates the activity of immediate early genes, such as c-fos, via cAMP-responsive element binding protein (reviewed in Ref. 13). Additional PKA targets proposed to play a role in behavioral sensitization include (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (39) and voltage-dependent sodium channels (36). All of these changes subsequent to psychostimulant exposure are interpreted as occurring in neurons postsynaptic to the dopamine neurons that project to this region, although G-protein signaling and transmitter synthesis and release in the dopamine cells themselves can also be altered by activation of dopamine autoreceptors (8, 40, 41). The first phenotype, resistance to cocaine, is what would be expected of a major disruption in cAMP signaling in postsynaptic neurons.

Mice lacking PKA-RIIbeta show normal responsiveness to amphetamine (14), which targets the same amine transporters as cocaine. It is premature to conclude that PKAII signaling is not involved in amphetamine responsiveness in mice, since mice contain two each of the RI and RII genes, and there is significant up-regulation of other R subunits in compensation for the lack of RIIbeta during development (14).

The second phenotype seen in flies is a failure to sensitize to repeated cocaine exposures. In flies, sensitization to cocaine can be blocked by ectopic G-protein expression in dopamine and serotonin neurons in the central nervous system, indicating a crucial role for these neurons and this signaling pathway in sensitization (42). However, sensitization results in enhanced nerve cord responses to dopamine agonists (43), most simply interpreted as enhanced responsiveness in neurons postsynaptic to these neurons, analogous to observations in vertebrates (36). Determining whether the failure of pka-RIIEP(2)2162 to sensitize results from deficient cAMP signaling in the aminergic neurons themselves or in neurons postsynaptic to these neurons will be addressed by further studies.

Mice lacking RIIbeta show a distinct phenotype of sensitizing more intensely than wild type mice to repeated amphetamine exposures (14). This observation clearly indicates an involvement for modulated PKA signaling in sensitization, but due to the complications of redundant genes and compensation mentioned above, more precise interpretations are not possible. Our results in flies indicate, however, involvement of PKA-RII in sensitization in a manner that any potential compensation by the remaining pka-RI gene cannot overcome.

Since pka-RIIEP(2)2162 lacks PKA-RII protein, the major gene product that mediates proper subcellular localization of PKA activity in cells, it is possible that abnormal redistribution of subcellular localization of PKA activity in the pka-RIIEP(2)2162 could be partly responsible for the abnormal responsiveness to cocaine. Potentially relevant is the recent report that dopaminergic modulation of a voltage-gated Na+ current which is involved in cocaine sensitization in rat hippocampal neurons requires PKAII anchoring (44, 45).

Resistance of pka-RIIEP(2)2162 to Ethanol-- We studied responses of pka-RIIEP(2)2162 to ethanol since a previous study indicates involvement of cAMP signaling in modulating sensitivity of Drosophila to ethanol (11). Mutations in amnesiac, rutabaga, and pka-C1, each thought to decrease cAMP levels or signaling, all show hypersensitivity to ethanol. Furthermore, the hypersensitivity of amn can be rescued by feeding of forskolin, an activator of adenylate cyclase (11). However, this study also indicated some complexity in the signaling pathways involved in these responses, since double mutant combinations of cAMP activating and repressing mutants gave paradoxical responses. This complexity is most readily explained by proposing the existence of neuronal signaling pathways, in which given neurons can positively or negatively affect activity of other neurons in the circuitry.

In the present study, we found that pka-RIIEP(2)2162 flies show robust resistance to ethanol. This is most simply interpreted as indicating that responses to cocaine and ethanol are mediated through a common PKA-dependent signaling step. However, further study will be required to confirm this interpretation.

Determination of whether the resistance of pka-RIIEP(2)2162 to ethanol is consistent with the previous observations of ethanol hypersensitivity of cAMP signaling deficient strains of Drosophila (11) is complicated. Recall that pka-RIIEP(2)2162 shows both an increased basal level of PKA as assayed in the absence of cAMP and a reduced level in the presence of cAMP, yielding overall reduced induction of PKA activity by cAMP. Thus, the simplest explanation is that these flies should be hypersensitive to ethanol since they show reduced cAMP-inducible signaling. However, this simple explanation may not hold for several reasons. First, flies with selectively altered PKAII signaling may show very different responses to ethanol than flies with overall reductions in PKA signaling. Since the cellular patterns of PKAI and -II expression and signaling have not been examined in Drosophila, it is possible that they regulate complementary or opposing neural circuits. Second, different types of developmental compensation may be possible in Drosophila strains with general defects in PKA signaling as opposed to selective defects in the PKAII pathway. Further studies will clearly be required to elucidate these complexities.

Defects in Ovarian Development of pka-RIIEP(2)2162-- A multinucleate nurse cell phenotype has been observed previously in ovaries from strains carrying mutations in pka-C1, encoding a PKA catalytic subunit (23, 34). pka-C1 interacts genetically with cut, a gene encoding a homeodomain nuclear protein, as a dominant enhancer of the multinucleate cell phenotype in early oogenesis (46). As expected, we found that pka-RIIEP(2)2162 flies show a multinucleate cell phenotype similar to that seen in pka-C1 and cut. However, pka-RIIEP(2)2162 also shows some unique phenotypes, such as the loss of ring canals from fused nurse cells and extra posterior follicle epithelial layers, suggesting that PKA-RII regulatory subunits exert more complicated functions than simply regulating catalytic activity of C subunits. One possible explanation is that the subcellular localization of PKA activity, which would expect to be disrupted in pka-RIIEP(2)2162 flies, might be required for normal oogenesis. Given that PKA-RII is the major mediator of subcellular localization of PKA activity through the interaction with AKAPs (47), it will be interesting to study the role of AKAPs in ovarian development.

Precisely what role(s) PKA signaling plays during the formation and maturation of ovarian follicles is not clear. Other signaling pathways, including Notch/Delta (48-50), Egfr (51), and hedgehog (52), have also been shown genetically to be required for these processes of oogenesis, and it is likely from the various genetic interactions observed that these pathways overlap or intersect in complex ways. For example, based on loss-of-function mutant interactions, PKA signaling may regulate early oogenesis downstream of cut gene function; however, loss-of-function cut mutations also suppress Notch loss-of-function ovary phenotypes (46), suggesting a link between these two signaling pathways.

Locomotor Arrhythmicity of pka-RIIEP(2)2162-- Pharmacological and genetic studies suggest that cAMP signaling plays a prominent role in the manifestation of circadian rhythms in both vertebrate and invertebrate model systems (9, 53-57). In Drosophila, the analyses of pka-C1 and dunce show that the cAMP signaling likely participates in the light-resetting mechanism (57) and/or locomotor-output pathways (9). Consistent with these observations, pka-RIIEP(2)2162 shows obvious locomotor arrhythmicity. However, the lack of PKAII does not completely abolish the free-running rhythm in pka-RIIEP(2)2162 flies, since a weak rhythm lasts at least for the 2-3 days in DD conditions. This observation is similar to the phenotype of pka-C1 flies, which show obvious locomotor arrhythmicity but normal period protein oscillation (9). Our observation supports the view that PKA is involved in the locomotor output pathway and indicates that PKAII is a major player in this process.

    ACKNOWLEDGEMENTS

We thank the Berkeley Drosophila Genome Center for the line EP(2)2162 and for web-based computer resources that allowed its identification. We thank Uli Muller for generous and useful experimental advice and Stanley McKnight and the members of our laboratories for helpful comments on the manuscript. We thank Dan Kalderon for the generous gift of anti-RII antibodies.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant GM/DA 27318 (to J. H.) and National Science Foundation Grant IBN-9723350 (to C. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF274008.

Dagger To whom correspondence should be addressed: Dept. of Biology, Gilmer Hall, University of Virginia, Charlottesville, VA 22903. Tel.: 804-982-5608; Fax: 804-982-5626; E-mail: jh6u@virginia.edu.

Published, JBC Papers in Press, April 25, 2000, DOI 10.1074/jbc.M002460200

    ABBREVIATIONS

The abbreviations used are: PKA, cAMP-dependent protein kinase; PKAII, type II cAMP-dependent protein kinase; PKA-RII, type II PKA regulatory subunit; AKAPs, protein kinase A-anchoring proteins; BDGP, Berkeley Drosophila Genome Project.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Schwartz, J. H., and Greenberg, S. M. (1987) Annu. Rev. Neurosci. 10, 459-476
2. Yin, J. C., Wallach, J. S., Del Vecchio, M., Wilder, E. L., Zhou, H., Quinn, W. G., and Tully, T. (1994) Cell 79, 49-58
3. Davis, R. L., Cherry, J., Dauwalder, B., Han, P. L., and Skoulakis, E. (1995) Mol. Cell. Biochem. 149-150, 271-278
4. Connolly, J. B., Roberts, I. J., Armstrong, J. D., Kaiser, K., Forte, M., Tully, T., and O'Kane, C. J. (1996) Science 274, 2104-2107
5. Goodwin, S. F., Del Vecchio, M., Velinzon, K., Hogel, C., Russell, S. R., Tully, T., and Kaiser, K. (1997) J. Neurosci. 17, 8817-8827
6. Mayford, M., and Kandel, E. R. (1999) Trends Genet. 15, 463-470
7. Davis, G. W., DiAntonio, A., Petersen, S. A., and Goodman, C. S. (1998) Neuron 20, 305-315
8. Pothos, E. N., Przedborski, S., Davila, V., Schmitz, Y., and Sulzer, D. (1998) J. Neurosci. 18, 5575-5585
9. Majercak, J., Kalderon, D., and Edery, I. (1997) Mol. Cell. Biol. 17, 5915-5922
10. Chyb, S., Hevers, W., Forte, M., Wolfgang, W. J., Selinger, Z., and Hardie, R. C. (1999) J. Neurosci. 19, 8799-8807
11. Moore, M. S., DeZazzo, J., Luk, A. Y., Tully, T., Singh, C. M., and Heberlein, U. (1998) Cell 93, 997-1007
12. Pandey, S. C. (1998) Mol. Neurobiol. 17, 1-15
13. Nestler, E. J., and Aghajanian, G. K. (1997) Science 278, 58-63
14. Brandon, E. P., Logue, S. F., Adams, M. R., Qi, M., Sullivan, S. P., Matsumoto, A. M., Dorsa, D. M., Wehner, J. M., McKnight, G. S., and Idzerda, R. L. (1998) J. Neurosci. 18, 3639-3649
15. Taylor, S. S., Buechler, J. A., and Yonemoto, W. (1990) Annu. Rev. Biochem. 59, 971-1005
16. Scott, J. D. (1991) Pharmacol. Ther. 50, 123-145
17. Carre, I. A., and Edmunds, L. N., Jr. (1992) J. Biol. Chem. 267, 2135-2137
18. Burton, K. A., Johnson, B. D., Hausken, Z. E., Westenbroek, R. E., Idzerda, R. L., Scheuer, T., Scott, J. D., Catterall, W. A., and McKnight, G. S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11067-11072
19. Cadd, G., and McKnight, G. S. (1989) Neuron 3, 71-79
20. Kalderon, D., and Rubin, G. M. (1988) Genes Dev. 2, 1539-1556
21. Foster, J. L., Guttman, J. J., Hall, L. M., and Rosen, O. M. (1984) J. Biol. Chem. 259, 13049-13055
22. Muller, U. (1997) J. Neurobiol. 33, 33-44
23. Lane, M. E., and Kalderon, D. (1993) Genes Dev. 7, 1229-1243
24. Perrimon, N. (1996) Cell 86, 513-516
25. Amieux, P. S., Cummings, D. E., Motamed, K., Brandon, E. P., Wailes, L. A., Le, K., Idzerda, R. L., and McKnight, G. S. (1997) J. Biol. Chem. 272, 3993-3998
26. Rorth, P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 12418-12422
27. Kumon, A., Nishiyama, K., Yamamura, H., and Nishizuka, Y. (1972) J. Biol. Chem. 247, 3726-3735
28. McClung, C., and Hirsh, J. (1998) Curr. Biol. 8, 109-112
29. Rosen, O. M., and Erlichman, J. (1975) J. Biol. Chem. 250, 7788-7794
30. Inoue, H., and Yoshioka, T. (1997) Biochem. Biophys. Res. Commun. 235, 223-226
31. Rangel-Aldao, R., and Rosen, O. M. (1976) J. Biol. Chem. 251, 7526-7529
32. Kuo, J. F., and Greengard, P. (1969) Proc. Natl. Acad. Sci. U. S. A. 64, 1349-1355
33. Takio, K., Smith, S. B., Krebs, E. G., Walsh, K. A., and Titani, K. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 2544-2548
34. Lane, M. E., and Kalderon, D. (1995) Mech. Dev. 49, 191-200
35. Kalivas, P. W. (1995) in The Neurobiology of Cocaine: Cellular and Molecular Mechanisms (Hammer, Ronald P., Jr., ed) , pp. 81-98, CRC Press, Inc., Boca Raton, FL
36. White, F. J., Hu, X.-T., Henry, D. J., and Zhang, S.-F. (1995) in The Neurobiology of Cocaine: Cellular and Molecular Mechanisms (Hammer, Ronald P., Jr., ed) , pp. 91-119, CRC Press, Inc., Boca Raton, FL
37. Pierce, R. C., and Kalivas, P. W. (1997) Brain Res. Rev. 25, 192-216
38. Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M., and Nestler, E. J. (1991) Brain Res. 548, 100-110
39. Pierce, R. C., Born, B., Adams, M., and Kalivas, P. W. (1996) J. Pharmacol. Exp. Ther. 278, 384-392
40. O'Hara, C. M., Uhland-Smith, A., O'Malley, K. L., and Todd, R. D. (1996) J. Pharmacol. Exp. Ther. 277, 186-192
41. Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., and Caron, M. G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4029-4034
42. Li, H., Chaney, S., Forte, M., and Hirsh, J. (2000) Curr. Biol. 10, 211-214
43. Andretic, R., Chaney, S., and Hirsh, J. (1999) Science 285, 1066-1068
44. Cantrell, A. R., Smith, R. D., Goldin, A. L., Scheuer, T., and Catterall, W. A. (1997) J. Neurosci. 17, 7330-7338
45. Cantrell, A. R., Scheuer, T., and Catterall, W. A. (1999) J. Neurosci. 19, 5301-5310
46. Jackson, S. M., and Blochlinger, K. (1997) Development 124, 3663-3672
47. Colledge, M., and Scott, J. D. (1999) Trends Cell Biol. 9, 216-221
48. Ruohola, H., Bremer, K. A., Baker, D., Swedlow, J. R., Jan, L. Y., and Jan, Y. N. (1991) Cell 66, 433-449
49. Xu, T., Caron, L. A., Fehon, R. G., and Artavanis-Tsakonas, S. (1992) Development 115, 913-922
50. Bender, L. B., Kooh, P. J., and Muskavitch, M. A. (1993) Genetics 133, 967-978
51. Goode, S., Wright, D., and Mahowald, A. P. (1992) Development 116, 177-192
52. Forbes, A. J., Lin, H., Ingham, P. W., and Spradling, A. C. (1996) Development 122, 1125-1135
53. Eskin, A., Corrent, G., Lin, C. Y., and McAdoo, D. J. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 660-664
54. Eskin, A., and Takahashi, J. S. (1983) Science 220, 82-84
55. Nikaido, S. S., and Takahashi, J. S. (1989) Neuron 3, 609-619
56. Carre, I. A., and Edmunds, L. N., Jr. (1993) J. Cell Sci. 104, 1163-1173
57. Levine, J. D., Casey, C. I., Kalderon, D. D., and Jackson, F. R. (1994) Neuron 13, 967-974


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Schwaerzel, A. Jaeckel, and U. Mueller
Signaling at A-Kinase Anchoring Proteins Organizes Anesthesia-Sensitive Memory in Drosophila
J. Neurosci., January 31, 2007; 27(5): 1229 - 1233.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
P. H. Taghert and O. T. Shafer
Mechanisms of Clock Output in the Drosophila Circadian Pacemaker System
J Biol Rhythms, December 1, 2006; 21(6): 445 - 457.
[Abstract] [PDF]


Home page
GeneticsHome page
L. S. Collier, K. Suyama, J. H. Anderson, and M. P. Scott
Drosophila Costal1 Mutations Are Alleles of Protein Kinase A That Modulate Hedgehog Signaling
Genetics, June 1, 2004; 167(2): 783 - 796.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. Yoshida, H-A. J. Muller, A. Wodarz, and A. Ephrussi
PKA-R1 spatially restricts Oskar expression for Drosophila embryonic patterning
Development, March 15, 2004; 131(6): 1401 - 1410.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. R. Terman and A. L. Kolodkin
Nervy Links Protein Kinase A to Plexin-Mediated Semaphorin Repulsion
Science, February 20, 2004; 303(5661): 1204 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. W. Wolf, A. R. Rodan, L. T.-Y. Tsai, and U. Heberlein
High-Resolution Analysis of Ethanol-Induced Locomotor Stimulation in Drosophila
J. Neurosci., December 15, 2002; 22(24): 11035 - 11044.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. R. Rodan, J. A. Kiger Jr, and U. Heberlein
Functional Dissection of Neuroanatomical Loci Regulating Ethanol Sensitivity in Drosophila
J. Neurosci., November 1, 2002; 22(21): 9490 - 9501.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Berke and C.-F. Wu
Regional Calcium Regulation within Cultured Drosophila Neurons: Effects of Altered cAMP Metabolism by the Learning Mutations dunce and rutabaga
J. Neurosci., June 1, 2002; 22(11): 4437 - 4447.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Constantinescu, A. S. Gordon, and I. Diamond
cAMP-dependent Protein Kinase Types I and II Differentially Regulate cAMP Response Element-mediated Gene Expression. IMPLICATIONS FOR NEURONAL RESPONSES TO ETHANOL
J. Biol. Chem., May 17, 2002; 277(21): 18810 - 18816.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. M. Jackson and C. A. Berg
An A-kinase anchoring protein is required for Protein kinase A regulatory subunit localization and morphology of actin structures during oogenesis in Drosophila
Development, January 10, 2002; 129(19): 4423 - 4433.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/27/20588    most recent
M002460200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, S. K.
Right arrow Articles by Hirsh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, S. K.
Right arrow Articles by Hirsh, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement